Multiple endocrine neoplasia type 1 MRI

Multiple endocrine neoplasia type 1 Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Multiple endocrine neoplasia type 1 from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Multiple endocrine neoplasia type 1 MRI On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 1 MRI All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Multiple endocrine neoplasia type 1 MRI
CDC on Multiple endocrine neoplasia type 1 MRI
Multiple endocrine neoplasia type 1 MRI in the news
Blogs on Multiple endocrine neoplasia type 1 MRI
Directions to Hospitals Treating Multiple endocrine neoplasia type 1
Risk calculators and risk factors for Multiple endocrine neoplasia type 1 MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

MRI

Insulinoma

• Dynamic MRI with fast gradient echo sequences following bolus injection of contrast medium may aid the detection of these tumours
• T1 C+ (Gd): typically shows enhancement, although contrast enhancement may not improve tumour visualisation compared with non-contrast images